Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Opin Pharmacol. 2008 Feb;8(1):42-9. Epub 2007 Nov 26.

Drugs acting on SUR1 to treat CNS ischemia and trauma.

Author information

  • 1Department of Neurosurgery, University of Maryland School of Medicine, 22 S. Greene St., Suite 12SD, Baltimore, MD 21201-1595, USA. msimard@smail.umaryland.edu

Abstract

Sulfonylurea receptor 1 (SUR1) is a molecule with more diverse and critically important functions than previously recognized. Long viewed simply as a subunit involved in formation of a subset of K(ATP) channels, accumulating evidence indicates that SUR1 is newly upregulated in CNS ischemia and injury and is surprisingly promiscuous in its association with different pore-forming subunits, which endow it with new roles not previously envisioned. In this review, we focus on the SUR1-regulated NC(Ca-ATP) channel, its emerging role in CNS ischemia and trauma, and the growing evidence from preclinical and clinical studies demonstrating the potential importance of block of SUR1 by sulfonylureas such as glibenclamide (glyburide) in conditions as seemingly diverse as stroke and spinal cord injury.

PMID:
18032110
[PubMed - indexed for MEDLINE]
PMCID:
PMC2265539
Free PMC Article

Images from this publication.See all images (3)Free text

Figure 1
Figure 2
Figure 3
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk